Company receives USFDA approval for Valbenazine Capsules Revenue from operations at Rs. 62,075 mn, up 21% YoY Research & Development...
Read moreNE BUSINESS BUREAU CHENNAI/AHMEDABAD, AUG 1 Mumbai-based Rubicon Research Limited has filed its Draft Red Herring Prospectus (https://www.icicisecurities.com/Upload/ArticleAttachments/Paras%20Healthcare%20Limited%20-%20DRHP.pdf) with market...
Read moreNE SCIENCE AND TECH BUREAU AHMEDABAD, JULY 31 Gujarat Technological University and the National Institute of Design (NID) have obtained...
Read moreNE BUSINESS BUREAU HYDERABAD, JULY 29 Dr Reddy’s Laboratories Ltd on Monday announced that the European Medicines Agency’s (EMA) Committee...
Read moreNE BUSINESS BUREAU CHENNAI, JULY 28 Pharmaceutical major Dr Reddy's Laboratories on Saturday reported a drop of 0.8 per cent...
Read moreLEQSELVI delivered statistically significant efficacy across two Phase 3 clinical trials At baseline, the average patient had only 13% scalp...
Read moreA discount of ₹ 64 per equity share is being offered to eligible employees bidding in the employee reservation portion....
Read moreNE HEALTH BUREAU HYDERABAD JULY 18 Dr Reddy’s Laboratories Ltd. on Thursday announced that it has entered into a non-exclusive...
Read moreNE HEALTH BUREAU CHENNAI, JULY 16 The Indian Medical Association (IMA) recently unveiled a special booklet titled ‘Headache Algorithm: A...
Read moreThe issue of Sai Life Sciences includes an offer-for-sale of up to 6,15,73,120 equity shares by its promoters and existing...
Read moreEmail:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com